Kimberly Drenser

This inventor holds 11 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 3 EPO patents. Top assignees: Retinal Solutions LLC, Retinol Solutions LLC, Other. Active years: 2015-2025.

USPTO Granted Patents = 11 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 3

EPO Patents = 3 (Patent Applications = 4)

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 8(Granted Patents)

Location History:

Bloomfield, MI (US) (2015)
Novi, MI (US) (2016 - 2021)
Rochester, MI (US) (2021)

Company Filing History:

9 out of 9

Retinal Solutions LLC

patents

1 out of 1

Retinol Solutions LLC

patent

1 out of 834,411

Other

patents

Years Active: 2015-2025

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12485158 - NORRIN INDUCED EXPRESSION OF GENES AND USE THEREOF TO TREAT DISEASE (2025-12-02),

2. 11198714 - Synthetic truncated norrin protein (2021-12-14),

3. 11041863 - Frizzled-4 mutation indicator of retinopathy and intrauterine growth restriction (2021-06-22),

4. 10799557 - Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema (2020-10-13),

5. 10703787 - Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema (2020-07-07),

6. 10669321 - Retinal capillary regeneration with synthetic norrin protein (2020-06-02),

7. 10206978 - Norrin regulation of junction proteins and the use thereof to treat epithelial or endothelial membrane leakage induced edema (2019-02-19),

8. 10202429 - Norrin regulation of cellular production of junction proteins and use to treat retinal vasculature edema (2019-02-12),

9. 9622657 - Automated system for measurement of zone 1 in assessment of severity of retinopathy of prematurity (2017-04-18),

10. 9504649 - Method and compositions for genetic and retinal disease (2016-11-29),

11. 9114078 - Methods and compositions for genetic and retinal disease (2015-08-25),

Title: The Innovative Contributions of Kimberly Drenser

Introduction

Kimberly Drenser is a prominent inventor based in Novi, MI (US), known for her significant contributions to the field of biotechnology. With a total of 10 patents to her name, she has made remarkable advancements in understanding and treating various medical conditions.

Latest Patents

Among her latest patents is the development of a synthetic truncated norrin protein. This innovative protein retains the cysteine-knot motif and frizzled-4 binding properties, featuring a mutation that extends its biological half-life in vivo. Another notable patent involves a method for determining the necessity of pre-term birth treatment by analyzing biological samples for specific Frizzled4 gene variations. These inventions highlight her commitment to improving health outcomes through scientific research.

Career Highlights

Throughout her career, Kimberly has worked with companies such as Retinal Solutions LLC and Retinol Solutions LLC. Her work has focused on developing solutions that address critical health issues, particularly in the field of retinal health.

Collaborations

Kimberly has collaborated with esteemed professionals in her field, including Michael T Trese and Antonio Capone. These partnerships have further enhanced her research and innovation efforts.

Conclusion

Kimberly Drenser's contributions to biotechnology through her patents and collaborations underscore her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments and technologies.